EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PKC Inhibition Improves Human Penile Vascular Function and the NO/cGMP Pathway in Diabetic Erectile Dysfunction: The Role of NADPH Oxidase

Mariam El Assar iD, José M La Fuente, Patricia Sosa, Argentina Fernández, Augusto J Pepe-Cardoso, Juan I Martínez-Salamanca iD, Leocadio Rodríguez-Mañas iD, Javier Angulo iD

International Journal of Molecular Sciences · 07.03.2024 · 25 (6) · 3111

DOI: 10.3390/ijms25063111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.03.2024. Verfasst von Mariam El Assar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fundación para la Investigación Biomédica del Hospital de Getafe, 28905 Getafe, Spain. Hauptthemen laut MEDLINE: Erectile Dysfunction, Diabetes Mellitus. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Economy and Competitiveness and co-financed by FEDER funds (Instituto de Salud Carlos III), Ministry of Economy and Competitiveness.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Erectile dysfunction (ED) is a frequent and difficult-to-treat condition in diabetic men. Protein kinase C (PKC) is involved in diabetes-related vascular and cavernosal alterations. We aimed to evaluate the role of PKC in endothelial dysfunction and NO/cGMP impairment associated with diabetic ED in the human corpus cavernosum (CC) and penile resistance arteries (PRAs) and the potential mechanisms involved. Functional responses were determined in the CC and PRAs in patients with non-diabetic ED and diabetic ED undergoing penile prosthesis insertion. PKC activator 12,13-phorbol-dibutyrate (PDBu) impaired endothelial relaxations and cGMP generation in response to acetylcholine in the CC from non-diabetic ED. PDBu also impaired responses to a PDE5 inhibitor, sildenafil, in non-diabetic ED patients. Conversely, a PKC inhibitor, GF109203X, improved endothelial, neurogenic, and PDE5-inhibitor-induced relaxations and cGMP generation only in the CC in diabetic ED patients. Endothelial and PDE5-inhibitor-induced vasodilations of PRAs were potentiated only in diabetes. Improvements in endothelial function in diabetes were also achieved with a specific inhibitor of the PKCβ2 isoform or an NADPH-oxidase inhibitor, apocynin, which prevented PDBu-induced impairment in non-diabetic patients. PKC inhibition counteracted NO/cGMP impairment and endothelial dysfunction in diabetes-related ED, potentially improving response to PDE5 inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erectile DysfunctionDiabetes MellitusMaleHumansProtein Kinase CSildenafil CitratePenisPhosphodiesterase 5 InhibitorsPenile Erection

Stichwörter der Autor:innen

NADPH oxidaseNO/cGMP pathwaydiabetesendothelial dysfunctionerectile dysfunctionhuman corpus cavernosumhuman penile arteriesprotein kinase C

Substanzen

Protein Kinase CSildenafil CitratePhosphodiesterase 5 Inhibitors

Autor:innen und Institutionen

  • Fundación para la Investigación Biomédica del Hospital de Getafe, 28905 Getafe, Spain.
  • Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Instituto de Investigación IdiPaz, 28029 Madrid, Spain.
  • Serviço de Urologia, Centro Hospitalar e Universitário de Santo António (CHUdSA), 4099-001 Porto, Portugal.
  • Servicio de Histología-Investigación, Unidad de Investigación Traslacional en Cardiología-IRYCIS/UFV, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
  • Serviço de Urologia, Hospital Fernando da Fonseca, 2720-276 Amadora, Portugal.

ORCID-Profile: Mariam El Assar, Juan I Martínez-Salamanca, Leocadio Rodríguez-Mañas, Javier Angulo

Förderung

  • Ministry of Economy and Competitiveness and co-financed by FEDER funds (Instituto de Salud Carlos III)
  • Ministry of Economy and Competitiveness

Zitieren

APA

El Assar, M., La Fuente, J. M., Sosa, P., Fernández, A., Pepe-Cardoso, A. J., Martínez-Salamanca, J. I., Rodríguez-Mañas, L., & Angulo, J. (2024). PKC Inhibition Improves Human Penile Vascular Function and the NO/cGMP Pathway in Diabetic Erectile Dysfunction: The Role of NADPH Oxidase. International Journal of Molecular Sciences, 25(6), 3111. https://doi.org/10.3390/ijms25063111

Vancouver

El Assar M, La Fuente JM, Sosa P, Fernández A, Pepe-Cardoso AJ, Martínez-Salamanca JI, et al. PKC Inhibition Improves Human Penile Vascular Function and the NO/cGMP Pathway in Diabetic Erectile Dysfunction: The Role of NADPH Oxidase. International Journal of Molecular Sciences. 2024;25(6):3111. doi:10.3390/ijms25063111

BibTeX
@article{ElAssar2024,
  author = {El Assar, Mariam and La Fuente, José M and Sosa, Patricia and Fernández, Argentina and Pepe-Cardoso, Augusto J and Martínez-Salamanca, Juan I and Rodríguez-Mañas, Leocadio and Angulo, Javier},
  title = {PKC Inhibition Improves Human Penile Vascular Function and the NO/cGMP Pathway in Diabetic Erectile Dysfunction: The Role of NADPH Oxidase},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {6},
  pages = {3111},
  doi = {10.3390/ijms25063111}
}
Kostenlos starten →